ANAND POPLI: Open Payments
NPI 1619964814 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$586 in 17 payments from 8 companies in 2025. Trend: 2023 $340 · 2024 $241 · 2025 $586
Food & beverage: $507Education: $80
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $130 |
| LivaNova USA, Inc. | 2 | $124 |
| E.R. Squibb & Sons, L.L.C. | 4 | $85 |
| Teva Pharmaceuticals USA, Inc. | 1 | $80 |
| Lundbeck LLC | 4 | $68 |
| Vanda Pharmaceuticals Inc. | 2 | $39 |
| Neurocrine BioSciences, Inc. | 2 | $39 |
| Alkermes, Inc. | 1 | $21 |
Products named: CAPLYTA, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, COBENFY, ABILIFY MAINTENA, FANAPT, INGREZZA, VIVITROL.
Industry payments across IN — which companies pay providers there.
